Detalhe da pesquisa
1.
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.
Oncology
; 99(8): 491-498, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34000725
2.
Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosis.
Hepatol Res
; 50(11): 1234-1243, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32914512
3.
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
Oncology
; 94(4): 215-222, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29428943
4.
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial.
BMC Cancer
; 18(1): 633, 2018 Jun 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29866075
5.
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
J Gastroenterol Hepatol
; 33(10): 1780-1786, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-29645345
6.
Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: propensity score-matched analysis.
J Gastroenterol Hepatol
; 30(2): 337-44, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25091289
7.
Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study.
J Gastroenterol
; 53(4): 548-556, 2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28815329
8.
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
Anticancer Res
; 36(7): 3523-9, 2016 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-27354618
9.
Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
J Dig Dis
; 16(9): 505-12, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26121102